BIOWKS — Bio-Works Technologies AB Cashflow Statement
0.000.00%
- SEK100.18m
- SEK65.90m
- SEK25.47m
Annual cashflow statement for Bio-Works Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -44.7 | -9.84 | -46.1 | -56.3 | -38 |
Depreciation | |||||
Non-Cash Items | -0.393 | 0.418 | 1.08 | 0 | 0.125 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.32 | -4.7 | 4.67 | -3.25 | -5.81 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -43.4 | -13.4 | -39.9 | -59 | -43.2 |
Capital Expenditures | -0.326 | -0.942 | -1.12 | -0.86 | -0.008 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | — | 0.166 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.326 | -0.942 | -1.12 | -0.86 | 0.158 |
Financing Cash Flow Items | — | -2.71 | -0.132 | -0.027 | -1.23 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0.348 | 84 | 4.04 | 33.3 | 37.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -43.3 | 69.7 | -36.9 | -26.5 | -5.1 |